At NEORGANA, we are advancing the future of health through the sophisticated integration of regenerative science, precision medicine, and cellular innovation.
As an authorized partner of MUSECELL INNOVATIONS™ (MCI), we exclusively offer regenerative therapies in Mexico with Dezawa MuseCells and we hold the exclusive distribuitor in Mexico for the prestigious Dezawa Golden Bag, MCI’s signature innovation. This strategic collaboration positions us at the forefront of high-precision cell therapy globally, enabling us to provide state-of-the-art treatments grounded in the most rigorous international scientific standards.
At Neorgana, Dezawa MuseCellsTM are at the core of our cellular regeneration protocols, offering a refined, next-generation approach to whole-body rejuvenation and long-term tissue renewal.
We recognize the uniqueness of each individual and design personalized treatment plans.
The medical ethics of our team and the safety of our patients are our top priority.
Founder & CEO of Neorgana
Mexito City
Omar Novelo is a visionary entrepreneur and expert in healthcare innovation, with a strong background in building regenerative medicine ventures. As the founder and CEO of Neorgana, he has led the company’s strategic growth into one of the most exclusive providers of advanced longevity and cell-based therapies in Latin America.
With over a decade of experience in high-level health business development, Omar has forged strategic partnerships with world-renowned scientists, cellular laboratories, and wellness centers to bring cutting-edge technologies—such as MUSE Cells™, exosome therapies, and epigenetic peptides—into real-world clinical application.
Under his leadership, Neorgana has become synonymous with excellence in integrative medicine, offering elite-level cellular therapies that prioritize safety, innovation, and results. Omar’s dedication to creating a future where regenerative medicine is both accessible and transformative continues to position Neorgana at the forefront of the global longevity movement.
Chief Medical Advisor – Neorgana
Dr. Matt Cook serves as Chief Medical Advisor of Neorgana, bringing a unique combination of clinical precision, technological innovation, and visionary expertise in regenerative and integrative medicine.
A board-certified anesthesiologist with extensive experience in functional and cellular medicine, Dr. Cook is internationally recognized as one of the foremost authorities in advanced therapeutics—ranging from peptide therapy, exosome and stem cell applications, to functional neuromodulation and personalized longevity protocols. Over the course of his career, he has worked with thousands of patients, including professional athletes, C-suite executives, and individuals with complex, treatment-resistant conditions, delivering transformative outcomes through individualized, science-based care.
At Neorgana, Dr. Cook is responsible for the strategic development of our clinical programs and therapeutic standards. His deep understanding of human physiology, cellular repair mechanisms, and bio-regulatory medicine allows us to integrate cutting-edge biotechnologies such as Dezawa Muse Cells™, MuseExosomes™, and precision peptide regimens into protocols that are both safe and profoundly effective.
His leadership ensures that Neorgana remains at the forefront of regenerative science—where medical innovation meets the art of healing.
National Medical Director – Neorgana
Specialist in Regenerative and Integrative Medicine
Mexito City
Dr. José Omar Novelo is an expert in regenerative medicine and the lead architect of Neorgana’s clinical protocols in Mexico. With a strong foundation in integrative clinical care, he has devoted his career to advancing cell-based and peptide therapies for neurodegenerative diseases, metabolic disorders, autoimmune conditions, and age-related decline.
Trained both in Mexico and internationally, Dr. Novelo integrates advanced regenerative treatments—including Dezawa MUSECells™, intravenous exosomes, and umbilical cord plasma—to deliver personalized therapies with measurable biological outcomes.
As Neorgana’s National Medical Director, he oversees the implementation of clinical programs with precision and a human-centered approach, driving forward a model of advanced medicine tailored to each patient’s unique profile. His leadership has positioned Neorgana as a national benchmark in high-end regenerative healthcare. His work continues to attract high-profile patients and health-conscious individuals seeking next-generation medical solutions.
Managing Partner – Middle East & North Africa
Mohanad Ghabra leads Neorgana’s presence across the Middle East and North Africa (MENA) region as Managing Partner. With deep cultural insight and a refined understanding of the region’s unique dynamics, Mohanad ensures that Neorgana’s operations in MENA reflect the highest standards of service, discretion, and personalization.
With years of experience serving high-profile clients across both public and private sectors, he brings a rare ability to anticipate expectations, deliver with precision, and build lasting trust. His leadership enables us to offer a true concierge experience—tailored not only to the needs but also to the values and traditions of the region’s most discerning clientele.
As we launch our state-of-the-art Longevity & Biohacking Clinic in the Middle East—offering the world’s most advanced biotechnology for wellness optimization and the treatment of complex medical conditions—Mohanad plays a key role in bridging global innovation with local sophistication.
Specialist in Pain Medicine and Interventional Algology
Dr. Sara Gabriela González Sánchez is a medical doctor graduated from Universidad La Salle, with specialized training in Anesthesiology at Hospital Ángeles Metropolitano. Her clinical focus has evolved toward advanced pain management and palliative care, having completed a high-specialty program at the National Institute of Medical Sciences and Nutrition Salvador Zubirán in affiliation with the National Autonomous University of Mexico (UNAM).
She has extensive training in regional anesthesia (ARMTY) and advanced interventional pain procedures through diplomas from AMETD and Universidad Panamericana. Currently, she serves as an adjunct professor in both basic and advanced interventional diplomas at AMETD and holds the position of Delegate on the Board of Directors of the Mexican Association for the Study and Treatment of Pain (AMETD).
Dr. González Sánchez practices at renowned institutions such as Hospital Ángeles Pedregal and Hospital Punta Médica, where she applies a comprehensive and cutting-edge interventional approach to the treatment of acute and chronic pain, in alignment with the highest standards of regenerative and personalized medicine.
